MEI Pharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q4 2015 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
MEI Pharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q4 2015 to Q2 2024.
  • MEI Pharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 6.66M shares, unchanged year-over-year.
  • MEI Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 6.66M shares, unchanged from 2023.
  • MEI Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 6.66M shares, a 6.49% increase from 2022.
  • MEI Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 6.26M shares, a 94.5% decline from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 6.66M 0 0% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-19
Q1 2024 6.66M 0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 6.66M 0 0% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 6.66M 0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 6.66M +406K +6.49% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-19
Q1 2023 6.66M +10K +0.15% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 6.66M -121M -94.8% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 6.66M -107M -94.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 6.26M -108M -94.5% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-26
Q1 2022 6.65M -106M -94.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 128M +13.7M +12% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-09
Q3 2021 114M -1.04M -0.91% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 114M +23.4M +25.7% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-08
Q1 2021 113M +6.56M +6.19% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 114M +35.9M +45.7% Oct 1, 2020 Dec 31, 2020 10-Q/A 2022-05-23
Q3 2020 115M +41.3M +56.1% Jul 1, 2020 Sep 30, 2020 10-Q/A 2022-05-23
Q2 2020 91.1M +18.7M +25.8% Apr 1, 2020 Jun 30, 2020 10-K 2022-09-08
Q1 2020 106M +34.8M +48.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 78.6M +4.63M +6.26% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 73.6M +2.74M +3.87% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 72.4M +31M +74.7% Apr 1, 2019 Jun 30, 2019 10-K/A 2022-05-23
Q1 2019 71.2M +33.8M +90.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 74M +36.5M +97.7% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-06
Q3 2018 70.9M +33.6M +90.3% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-08
Q2 2018 41.4M +4.49M +12.2% Apr 1, 2018 Jun 30, 2018 10-K 2020-09-09
Q1 2018 37.4M +277K +0.75% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 37.4M +197K +0.53% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q3 2017 37.2M +1.5M +4.19% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 36.9M Apr 1, 2017 Jun 30, 2017 10-K 2019-08-28
Q1 2017 37.2M +2.75M +7.99% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 37.2M +2.79M +8.12% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-08
Q3 2016 35.7M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q1 2016 34.4M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 34.4M Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.